Statistics for National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey
Total visits
views | |
---|---|
National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey | 0 |
Total visits per month
views | |
---|---|
November 2023 | 0 |
December 2023 | 0 |
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |